Consultation on potential Ebola therapies and vaccines
Place: Geneva, Swizerland
Date: 4-5 September 2014
Date: 4-5 September 2014
The
current west African Ebola outbreak is unprecedented in size, complexity and
the strain it has imposed on health systems. There is intense public interest
in, and demand for, anything that offers hope of definitive treatment. A range
of unproven interventions-blood products, immune therapies, drugs and vaccines
are under different stages of development but none have yet been licensed for
standard use.
In
early August, an expert panel convened by WHO concluded that, in the particular
circumstances of this outbreak, and provided certain conditions are met, it is
ethical to offer such unproven interventions as potential treatments or for
prevention of infection.
This
week, on September 4-5, WHO is bringing together technical experts from the
groups developing Ebola interventions along with people working to overcome
Ebola virus disease including policy-makers from Ebola affected countries,
ethicists, clinicians, researchers, regulators and patient representatives.
The purpose of this meeting
- To obtain the most accurate information on the current state of development of the interventions.
- To achieve consensus on key issues to consider when making decisions about use of the interventions.
- To agree on how data should be gathered and shared.
- To inform national regulatory authorities about the status of potential products and foster contacts between affected countries and manufacturers.
No comments:
Post a Comment